About NKGen Biotech
Maximizing immune integrity through the development of unique natural killer (NK) cell therapies.
- Industry
- Biotechnology
- Company size
- 51-200 employees
- Headquarters
- Santa Ana, California
- Founded
- 2017
- Company type
- Public Company
- Company profile name
- NKGen Biotech, Inc.
NKGen Biotech is a clinical-stage biotechnology company harnessing the power of the body's immune system through the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies to treat neurodegenerative and oncological diseases utilizing our proprietary SNK (super-activated) platform.
The mission of NKGen Biotech is to improve patients' lives in a safe and natural way through innovative cell therapy products and to ultimately become the global leader in immune cell therapeutics.
More information can be found on our website www.nkgenbiotech.com
Specialties
- Immunotherapy
- Autologous Cell Therapy
- Biotechnology
- Cellular Therapeutics
- NK Cell Therapy
- Biopharmaceutical
- Immuno-oncology
- Allogeneic Cell Therapy
- Oncology
- Cell Therapy
- Alzheimer's Disease
- Neurodegenerative Disease
- and Parkinson's Disease
Company locations
3001 Daimler St, Santa Ana, California 92705, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
On LinkedIn
- Followers
- 7,271
- People linked to this company
- 53
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.